Arphra
feed
S&P 500
NASDAQ
DOW
VIX
US10Y
EUR/USD
GOLD
WTI
BTC

NECLIFE.NS

Nectar Lifesciences Limited
HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →
$12.01
Jun 02, 2026
AI Brief
Market cap
52w range
P / E
EPS
Volume
Revenue · FY

Explain this page

Arphra AI
Business description
· company · SEC profile

Nectar Lifesciences Limited

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Founded
IPO
Jul 18, 2005
Employees
1,686
HQ
Chandigarh
CEO
Sanjiv Goyal
CFO
Exchange
NSE
Fiscal year
Identifiers
· company_identifiers
CIK
CUSIPY6238X101
ISININE023H01027
FIGINECLIFE IN
LEI